EP2529756
Risperidon og/eða Paliperidone samsetning til ígræðslu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.5.2012EP published:
19.5.2021EP application number:
12170362.3
EP translation filed:
2.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
30.5.2032Expiry date:
30.5.2026Next due date:
31.5.2026
Title:
Risperidone and/or Paliperidone implant formulation
Timeline
Today
31.5.2012EP application
19.5.2021EP Publication
2.7.2021Translation submitted
15.8.2021Registration published
30.5.2026Expires
Owner
Name:
LABORATORIOS FARMACEUTICOS ROVI, S.A.Address:
c/Julián Camarillo, 35, 28037 Madrid, ES
Inventor
Name:
Gutierro Aduriz, IbonAddress:
28037 Madrid, ES
Name:
Franco Rodriguez, GuillermoAddress:
28037 Madrid, ES
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/EP2011/059000Date:
31.5.2011Country:
WO
Number:
PCT/EP2011/059001Date:
31.5.2011Country:
WO
Classification
Categories:
A61K 47/34, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.6.2021
Expires: 30.5.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 12.5.2022
Expires: 30.5.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 11.5.2023
Expires: 30.5.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 17.5.2024
Expires: 30.5.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 14
Paid: 12.5.2025
Expires: 30.5.2026
Payer: G.H. Sigurgeirsson ehf.